BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND BCL2, Bcl-2, 596, ENSG00000171791
1079 results:

  • 1. Optimizing long-term stability of siRNA using thermoassemble ionizable reverse pluronic-bcl2 micelleplexes.
    De A; Kang JH; Sauraj ; Lee OH; Ko YT
    Int J Biol Macromol; 2024 Apr; 264(Pt 2):130783. PubMed ID: 38471603
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update.
    Hediyal TA; Vichitra C; Anand N; Bhaskaran M; Essa SM; Kumar P; Qoronfleh MW; Akbar M; Kaul-Ghanekar R; Mahalakshmi AM; Yang J; Song BJ; Monaghan TM; Sakharkar MK; Chidambaram SB
    Front Immunol; 2024; 15():1324018. PubMed ID: 38449863
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
    Cao Q; Hajosch A; Kast RE; Loehmann C; Hlavac M; Fischer-Posovszky P; Strobel H; Westhoff MA; Siegelin MD; Wirtz CR; Halatsch ME; Karpel-Massler G
    Br J Cancer; 2024 May; 130(8):1365-1376. PubMed ID: 38396172
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702.
    Fiveash JB; Ye X; Peerboom DM; Mikkelsen T; Chowdhary S; Rosenfeld M; Lesser GJ; Fisher J; Desideri S; Grossman S; Leopold L; Nabors LB
    PLoS One; 2024; 19(1):e0291128. PubMed ID: 38285688
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Simulated microgravity induces DNA damage concurrent with impairment of DNA repair and activation of cell-type specific DNA damage response in microglial and glioblastoma cells.
    Singh R; Jaiswal A; Singh RP
    Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119679. PubMed ID: 38272357
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Bifidobacterium longum SX-1326 ameliorates gastrointestinal toxicity after irinotecan chemotherapy via modulating the P53 signaling pathway and brain-gut axis.
    Yue F; Zeng X; Wang Y; Fang Y; Yue M; Zhao X; Zhu R; Zeng Q; Wei J; Chen T
    BMC Microbiol; 2024 Jan; 24(1):8. PubMed ID: 38172689
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to bcl-2 inhibition in medulloblastoma.
    Qin N; Paisana E; Picard D; Leprivier G; Langini M; Custódia C; Cascão R; Conrad C; Peitzsch M; Stefanski A; Stühler K; Fischer U; Faria CC; Dietrich S; Reifenberger G; Remke M
    J Neurooncol; 2023 Nov; 165(2):329-342. PubMed ID: 37976029
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy-dependent type of cell death in glioblastoma cells.
    Reisbeck L; Linder B; Tascher G; Bozkurt S; Weber KJ; Herold-Mende C; van Wijk SJL; Marschalek R; Schaefer L; Münch C; Kögel D
    Am J Physiol Cell Physiol; 2023 Dec; 325(6):C1451-C1469. PubMed ID: 37899749
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The identification of BCL-XL and MCL-1 as key anti-apoptotic proteins in medulloblastoma that mediate distinct roles in chemotherapy resistance.
    Fitzgerald MC; O'Halloran PJ; Kerrane SA; Ní Chonghaile T; Connolly NMC; Murphy BM
    Cell Death Dis; 2023 Oct; 14(10):705. PubMed ID: 37898609
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. bcl2A1 is associated with tumor-associated macrophages and unfavorable prognosis in human gliomas.
    Gao L; Ye Z; Peng S; Lei P; Song P; Li Z; Zhou L; Hua Q; Cheng L; Wei H; Liu J; Cai Q
    Aging (Albany NY); 2023 Oct; 15(20):11611-11638. PubMed ID: 37889551
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Over-representation analysis of angiogenic factors in immunosuppressive mechanisms in neoplasms and neurological conditions during COVID-19.
    Chatterjee S; Sanjeev BS
    Microb Pathog; 2023 Dec; 185():106386. PubMed ID: 37865274
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.
    Haikazian S; Chen-Li DCJ; Johnson DE; Fancy F; Levinta A; Husain MI; Mansur RB; McIntyre RS; Rosenblat JD
    Psychiatry Res; 2023 Nov; 329():115531. PubMed ID: 37844352
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A preliminary study on the mechanism of VASH2 in childhood medulloblastoma.
    Liu W; Fu Y; Wang M; Zhao J; Chen J; Wang Y; Qin H
    Sci Rep; 2023 Oct; 13(1):17153. PubMed ID: 37821528
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein.
    Budassi F; Marchioro C; Canton M; Favaro A; Sturlese M; Urbinati C; Rusnati M; Romagnoli R; Viola G; Mariotto E
    Eur J Med Chem; 2023 Dec; 261():115824. PubMed ID: 37783101
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Epileptic versus neuro-oncological focus of management in pediatric patients with concurrent primary brain lesion and seizures: a systematic review.
    Gruber MD; Pindrik J; Damante M; Schulz L; Shaikhouni A; Leonard JR
    J Neurosurg Pediatr; 2023 Nov; 32(5):576-583. PubMed ID: 37728409
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Protective effect of vitamin B
    Sun RL; Wang HH; Gui ZC; Shuang-Guo ; Lin LB; Fan JX; Xue-Zhang ; Mao BY; Liu G; Liu WZ; Yue RZ; Yin YL; Wang QQ; Li P
    J Biochem Mol Toxicol; 2023 Oct; 37(10):e23403. PubMed ID: 37701944
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.
    Schoenfeld DA; Moutafi M; Martinez S; Djureinovic D; Merkin RD; Adeniran A; Braun DA; Signoretti S; Choueiri TK; Parisi F; Hurwitz M; Rimm DL; Wei W; Jilaveanu L; Kluger HM
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586773
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Chemical modification of curcumin increases its potency against hypopharyngeal carcinoma.
    Zhang L; Cheng L; Chen Z; Fang Y; Li C; Chen M; He P; Wu H; Wu J; Chen J
    J Drug Target; 2023 Sep; 31(8):867-877. PubMed ID: 37577780
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Lactate-induced up-regulation of PLEKHA4 promotes proliferation and apoptosis of human glioma cells].
    Ye J; Xu W; Xi B; Wang N; Chen T
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1071-1080. PubMed ID: 37488789
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium.
    Lee MD; Patel SH; Mohan S; Akbari H; Bakas S; Nasrallah MP; Calabrese E; Rudie J; Villanueva-Meyer J; LaMontagne P; Marcus DS; Colen RR; Balana C; Choi YS; Badve C; Barnholtz-Sloan JS; Sloan AE; Booth TC; Palmer JD; Dicker AP; Flanders AE; Shi W; Griffith B; Poisson LM; Chakravarti A; Mahajan A; Chang S; Orringer D; Davatzikos C; Jain R;
    Neuroradiology; 2023 Sep; 65(9):1343-1352. PubMed ID: 37468750
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 54.